Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × AMG 757 × 90 days × Clear all

Phase

Phase 3 3 Phase 1 2 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Specimen Handling 228 pembrolizumab 203 Magnetic Resonance Spectroscopy 187 Biopsy 139 Carboplatin 138 Cyclophosphamide 117 Nivolumab 113 Cisplatin 110 Paclitaxel 102 Radiotherapy 89 Gemcitabine 74 Bevacizumab 72 venetoclax 67 durvalumab 67 Dexamethasone 65 Oxaliplatin 60 Rituximab 58 Docetaxel 57 Ipilimumab 56 Fluorouracil 56 atezolizumab 55 Prednisone 54 Capecitabine 54 fludarabine 53 Etoposide 51 olaparib 49 Radiation 49 Drug Therapy 49 Doxorubicin 48 Cytarabine 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06745323 2026-03-03

DeLLphi-309

Amgen

Phase 2 Active not recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡